Pediatric Clinical Trial- Closed

First Ascent Biomedical in partnership with FIU and Nicklaus Children's Hospital executing 22 patient trial.

Dr. Diana Azzam, First Ascent's CSO, is leading a clinical trial for 22 pediatric patients across several cancer types including: Leukemia, Lymphoma, Rhabdomyosarcoma, Gliosarcoma, and others. Patient targets are under 18 and presenting with with recurrent or refractory cancer.

This trial has closed. Clinical results of the trial are being finalized. Publication of results expected Q3 2022 or before.

To learn more about this trial, please visit the trial homepage on at:

Ex Vivo Drug Sensitivity Testing and Mutation Profiling

46 views0 comments

Recent Posts

See All